Description
DASATIB 50 Tablet 60’s dasatinib 50mg tablets, 60-count: a potent cancer medication, dasatinib is a selective src family kinase inhibitor. This oral treatment is primarily indicated for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) in adults. It works by inhibiting the abnormal protein Bcr-Abl, which is responsible for uncontrolled cell growth in CML and ALL. The 50mg strength tablets are designed for once-daily dosing, providing effective management of Ph+ CML and ALL. Always consult with a healthcare provider for proper dosage and administration instructions.
Reviews
There are no reviews yet.